| Aurobindo Pharma Limited | 1,252 | 1,252G/0B | $0.6091 | -0.33% | 489↑ 532↓of 1021 | 2 | 17 |
| Sun Pharmaceutical Industries Inc. | 933 | 904G/29B | $3.0036 | -0.02% | 233↑ 263↓of 496 | 12 | 22 |
| NorthStar Rx LLC | 899 | 899G/0B | $1.5581 | -0.68% | 367↑ 454↓of 821 | 1 | 7 |
| Teva Pharmaceuticals USA Inc. | 812 | 795G/17B | $67.0552 | -0.52% | 337↑ 399↓of 736 | 4 | 14 |
| Rising Pharma Holdings Inc. | 764 | 763G/1B | $0.6930 | -0.05% | 353↑ 358↓of 711 | 1 | 7 |
| Major Pharmaceuticals | 734 | 734G/0B | $0.2619 | -0.23% | 295↑ 374↓of 669 | 25 | 8 |
| Dr. Reddy's Laboratories Inc. | 701 | 701G/0B | $2.1810 | -0.82% | 276↑ 275↓of 551 | 2 | 8 |
| Camber Pharmaceuticals Inc. | 668 | 668G/0B | $1.2152 | -0.25% | 299↑ 307↓of 606 | 1 | 7 |
| American Health Packaging | 639 | 638G/1B | $0.3431 | -0.11% | 291↑ 315↓of 606 | 35 | 3 |
| Mylan Pharmaceuticals Inc. | 628 | 623G/5B | $2.6461 | -0.27% | 251↑ 287↓of 538 | 7 | 10 |
| Zydus Pharmaceuticals (USA) Inc. | 625 | 618G/7B | $1.5353 | -0.48% | 258↑ 292↓of 550 | 2 | 9 |
| Lupin Pharmaceuticals Inc. | 557 | 552G/5B | $4.9927 | -0.14% | 191↑ 228↓of 419 | 2 | 14 |
| Alembic Pharmaceuticals Inc. | 523 | 523G/0B | $0.9482 | -0.40% | 225↑ 271↓of 496 | 2 | 2 |
| Chartwell RX LLC | 521 | 521G/0B | $0.5299 | -0.12% | 221↑ 263↓of 484 | 5 | 9 |
| Ascend Laboratories, LLC | 461 | 461G/0B | $1.1272 | -1.02% | 189↑ 214↓of 403 | — | 5 |
| Glenmark Pharmaceuticals Inc., USA | 444 | 444G/0B | $1.5769 | -0.06% | 173↑ 180↓of 353 | — | 8 |
| Actavis Pharma, Inc. | 439 | 438G/1B | $1.0474 | -0.43% | 157↑ 206↓of 363 | — | 11 |
| Strategic Sourcing Services LLC | 431 | 431G/0B | $0.2715 | -0.64% | 92↑ 189↓of 281 | 2 | 3 |
| Cardinal Health | 420 | 420G/0B | $0.1975 | -0.22% | 133↑ 184↓of 317 | 4 | 2 |
| Macleods Pharmaceuticals Limited | 418 | 418G/0B | $0.4435 | -0.43% | 179↑ 187↓of 366 | 1 | 1 |
| Hikma Pharmaceuticals USA Inc. | 414 | 414G/0B | $2.5965 | -0.23% | 130↑ 182↓of 312 | 2 | 3 |
| BluePoint Laboratories | 395 | 395G/0B | $2.8724 | -0.53% | 134↑ 198↓of 332 | 2 | 1 |
| Sandoz Inc. | 394 | 351G/43B | $22.2082 | -0.62% | 136↑ 168↓of 304 | 4 | 10 |
| AmerisourceBergen | 393 | 393G/0B | $0.3045 | -0.49% | 117↑ 207↓of 324 | — | 2 |
| Amneal Pharmaceuticals LLC | 388 | 359G/29B | $4.3447 | +0.73% | 141↑ 105↓of 246 | 2 | 17 |
| Solco Healthcare US LLC | 365 | 365G/0B | $0.2180 | -0.26% | 151↑ 197↓of 348 | 1 | 2 |
| Apotex Corp. | 362 | 350G/12B | $5.1281 | -0.92% | 129↑ 179↓of 308 | 1 | 9 |
| Heritage Pharmaceuticals Inc. | 317 | 317G/0B | $0.4637 | -0.65% | 132↑ 156↓of 288 | 1 | 7 |
| Accord Healthcare Inc. | 316 | 316G/0B | $0.6861 | -0.80% | 31↑ 54↓of 85 | 1 | 13 |
| Torrent Pharmaceuticals Limited | 315 | 315G/0B | $1.9297 | +0.52% | 155↑ 108↓of 263 | — | 2 |
| Cipla USA Inc. | 308 | 308G/0B | $1.5347 | -0.37% | 94↑ 111↓of 205 | — | 8 |
| Unichem Pharmaceuticals (USA) Inc. | 306 | 306G/0B | $0.1336 | +0.06% | 147↑ 131↓of 278 | — | 4 |
| Amneal Pharmaceuticals NY LLC | 306 | 306G/0B | $3.4496 | -0.20% | 129↑ 132↓of 261 | — | 8 |
| Upsher-Smith Laboratories LLC | 305 | 263G/42B | $3.1791 | -0.04% | 119↑ 107↓of 226 | 1 | 12 |
| AvPAK | 300 | 300G/0B | $0.2186 | -0.10% | 135↑ 146↓of 281 | 7 | 1 |
| ANI Pharmaceuticals, Inc. | 296 | 279G/17B | $3.0758 | -0.91% | 110↑ 156↓of 266 | 3 | 13 |
| Exelan Pharmaceuticals Inc. | 285 | 285G/0B | $0.2220 | +0.06% | 134↑ 128↓of 262 | — | — |
| Advagen Pharma Ltd. | 278 | 278G/0B | $0.3923 | +0.19% | 140↑ 136↓of 276 | — | 3 |
| Amneal Pharmaceuticals of New York LLC | 263 | 263G/0B | $3.0664 | -0.49% | 60↑ 89↓of 149 | — | 7 |
| Westminster Pharmaceuticals LLC | 263 | 263G/0B | $0.2553 | +1.44% | 156↑ 90↓of 246 | 1 | 1 |
| Padagis Israel Pharmaceuticals Ltd | 261 | 259G/2B | $3.3086 | -0.38% | 97↑ 148↓of 245 | — | 10 |
| Lannett Company Inc. | 258 | 258G/0B | $0.7849 | +0.73% | 97↑ 100↓of 197 | — | 6 |
| Strides Pharma Inc. | 247 | 247G/0B | $0.4113 | -0.56% | 89↑ 118↓of 207 | 1 | 3 |
| Epic Pharma LLC | 243 | 243G/0B | $0.4255 | -0.87% | 40↑ 79↓of 119 | 1 | 1 |
| Chain Drug Marketing Association | 227 | 227G/0B | $0.1217 | -0.81% | 43↑ 79↓of 122 | 3 | 3 |
| Endo USA Inc. | 219 | 204G/15B | $7.4497 | -0.77% | 82↑ 113↓of 195 | — | 8 |
| Granules Pharmaceuticals Inc. | 209 | 209G/0B | $0.5657 | -0.25% | 101↑ 95↓of 196 | — | 1 |
| Rugby Laboratories | 209 | 209G/0B | $0.4328 | +0.03% | 97↑ 90↓of 187 | 3 | 3 |
| Haleon US Holdings LLC | 203 | 0G/203B | $0.5315 | — | — | — | 8 |
| Ajanta Pharma USA Inc. | 194 | 194G/0B | $0.8119 | +0.87% | 91↑ 67↓of 158 | — | 5 |
| Novadoz Pharmaceuticals LLC | 191 | 191G/0B | $2.5705 | -0.54% | 86↑ 93↓of 179 | 3 | 2 |
| SpecGx LLC | 173 | 168G/5B | $1.6243 | +0.30% | 77↑ 78↓of 155 | — | 2 |
| L. Perrigo Company | 167 | 161G/6B | $0.2669 | -0.51% | 61↑ 97↓of 158 | — | 1 |
| Fresenius Kabi USA, LLC | 165 | 157G/8B | $24.5645 | -0.10% | 41↑ 49↓of 90 | — | 2 |
| Mylan Institutional LLC | 149 | 147G/2B | $25.2453 | +0.23% | 59↑ 58↓of 117 | 7 | — |
| Lifestar Pharma LLC | 148 | 148G/0B | $0.9349 | -0.48% | 65↑ 60↓of 125 | 2 | 2 |
| Quallent Pharmaceuticals Health LLC | 147 | 147G/0B | $4.5517 | -0.02% | 83↑ 64↓of 147 | 1 | 2 |
| Allergan, Inc. | 146 | 0G/146B | $40.6095 | -0.01% | 25↑ 46↓of 71 | — | 18 |
| Ingenus Pharmaceuticals LLC | 144 | 141G/3B | $3.7119 | -1.04% | 54↑ 70↓of 124 | 1 | 4 |
| Nivagen Pharmaceuticals Inc. | 137 | 137G/0B | $0.8472 | -0.56% | 37↑ 27↓of 64 | 2 | 5 |
| Viona Pharmaceuticals Inc. | 133 | 133G/0B | $0.4821 | -0.64% | 55↑ 77↓of 132 | — | 2 |
| Bionpharma Inc. | 131 | 131G/0B | $0.5987 | -0.69% | 54↑ 71↓of 125 | 2 | 2 |
| KVK-Tech Inc. | 130 | 130G/0B | $0.5254 | +0.50% | 51↑ 36↓of 87 | — | 4 |
| Cosette Pharmaceuticals, Inc. | 128 | 108G/20B | $4.1953 | -0.98% | 41↑ 65↓of 106 | — | 6 |
| Leading Pharma, LLC | 125 | 125G/0B | $0.8790 | — | 47↑ 55↓of 102 | 1 | 4 |
| ScieGen Pharmaceuticals, Inc. | 122 | 122G/0B | $0.0959 | +0.33% | 61↑ 58↓of 119 | — | 1 |
| Micro Labs Limited | 120 | 120G/0B | $0.6839 | +0.20% | 50↑ 51↓of 101 | 1 | 2 |
| Hospira Inc. | 119 | 117G/2B | $4.2938 | +1.34% | 27↑ 19↓of 46 | 2 | 3 |
| Jubilant Cadista Pharmaceuticals Inc. | 119 | 119G/0B | $0.2307 | -0.03% | 28↑ 36↓of 64 | — | 3 |
| Pfizer Inc. | 118 | 0G/118B | $62.7918 | +0.01% | 25↑ 17↓of 42 | — | 19 |
| RB Health (US) LLC | 110 | 0G/110B | $0.4154 | — | — | — | 5 |
| Method Pharmaceuticals LLC | 110 | 110G/0B | $0.2667 | +0.37% | 50↑ 44↓of 94 | — | 1 |
| Oceanside Pharmaceuticals | 108 | 108G/0B | $10.9894 | — | — | — | 5 |
| Bausch Health US LLC | 104 | 3G/101B | $34.0775 | — | — | — | 19 |
| Prasco Laboratories | 103 | 103G/0B | $14.2798 | -0.35% | 37↑ 50↓of 87 | — | 1 |
| Aurolife Pharma LLC | 99 | 99G/0B | $0.2476 | -0.16% | 43↑ 48↓of 91 | — | — |
| Taro Pharmaceuticals U.S.A. Inc. | 98 | 97G/1B | $0.8286 | -0.34% | 26↑ 38↓of 64 | — | 1 |
| Rhodes Pharmaceuticals L.P. | 97 | 83G/14B | $4.1055 | -0.06% | 35↑ 34↓of 69 | 1 | 1 |
| Viatris Specialty LLC | 95 | 3G/92B | $26.2128 | +17.47% | 12↑ 50↓of 62 | — | 21 |
| Slate Run Pharmaceuticals LLC | 94 | 94G/0B | $1.3342 | +0.22% | 20↑ 16↓of 36 | — | 3 |
| Alvogen Inc. | 94 | 94G/0B | $13.8918 | -0.77% | 27↑ 49↓of 76 | — | 2 |
| TruPharma LLC | 94 | 94G/0B | $1.0014 | +0.06% | 44↑ 35↓of 79 | — | 6 |
| Somerset Therapeutics, LLC | 93 | 93G/0B | $5.2654 | -0.18% | 40↑ 46↓of 86 | 1 | 1 |
| Biocon Pharma Inc. | 93 | 93G/0B | $2.4417 | -1.26% | 33↑ 53↓of 86 | — | 1 |
| Novartis Pharmaceuticals Corporation | 92 | 0G/92B | $766.98 | — | 13↑ 16↓of 29 | — | 15 |
| ScieGen Pharmaceuticals Inc. | 91 | 91G/0B | $0.2112 | +0.44% | 48↑ 41↓of 89 | — | — |
| Merck Sharp & Dohme LLC | 89 | 0G/89B | $84.8167 | +0.06% | 30↑ 21↓of 51 | — | 5 |
| Encube Ethicals, Inc. | 88 | 88G/0B | $0.8644 | -1.19% | 36↑ 49↓of 85 | — | — |
| AbbVie Inc. | 88 | 1G/87B | $1246.10 | — | 30↑ 31↓of 61 | — | 5 |
| Xiromed LLC | 88 | 88G/0B | $3.5147 | -0.38% | 37↑ 46↓of 83 | — | — |
| Time-Cap Labs Inc. | 86 | 86G/0B | $0.0803 | +0.03% | 43↑ 40↓of 83 | — | — |
| Bausch & Lomb Incorporated | 86 | 55G/31B | $21.5653 | -0.79% | 23↑ 31↓of 54 | 1 | 8 |
| Topco Associates LLC | 86 | 86G/0B | $0.3786 | — | — | 3 | 2 |
| Breckenridge Pharmaceutical Inc. | 85 | 85G/0B | $1.8106 | -0.59% | 45↑ 35↓of 80 | — | — |
| E. Fougera & Co. a division of Fougera Pharmaceuticals Inc. | 82 | 82G/0B | $0.5791 | +1.21% | 31↑ 26↓of 57 | — | — |
| Oxford Pharmaceuticals, LLC | 82 | 82G/0B | $0.0734 | -0.10% | 34↑ 45↓of 79 | — | — |
| Takeda Pharmaceuticals America, Inc. | 80 | 1G/79B | $29.7702 | -0.03% | 16↑ 27↓of 43 | — | 14 |
| Mayne Pharma | 78 | 65G/13B | $33.6632 | +1.55% | 14↑ 14↓of 28 | 3 | 6 |
| Sagent Pharmaceuticals | 78 | 78G/0B | $6.5949 | +0.19% | 23↑ 23↓of 46 | — | 1 |
| Eli Lilly and Company | 77 | 4G/73B | $629.82 | — | 27↑ 21↓of 48 | — | 4 |
| Modavar Pharmaceuticals LLC | 75 | 75G/0B | $0.1417 | -0.15% | 46↑ 29↓of 75 | — | — |
| Boehringer Ingelheim Pharmaceuticals Inc. | 73 | 1G/72B | $69.7151 | +0.01% | 39↑ 19↓of 58 | — | 3 |
| Janssen Pharmaceuticals Inc. | 70 | 0G/70B | $580.26 | -0.04% | 19↑ 32↓of 51 | — | 5 |
| Padagis US LLC | 70 | 68G/2B | $7.4901 | -1.09% | 19↑ 41↓of 60 | — | 6 |
| Legacy Pharmaceutical Packaging, LLC | 68 | 68G/0B | $0.0441 | -0.84% | 30↑ 38↓of 68 | 3 | 2 |
| AstraZeneca Pharmaceuticals LP | 67 | 2G/65B | $38.4998 | -0.06% | 19↑ 14↓of 33 | — | 6 |
| GlaxoSmithKline LLC | 67 | 0G/67B | $34.5981 | -0.03% | 18↑ 22↓of 40 | — | 6 |
| Eugia US LLC | 67 | 67G/0B | $12.8466 | -1.39% | 13↑ 21↓of 34 | 1 | 1 |
| Meitheal Pharmaceuticals Inc. | 63 | 62G/1B | $22.9237 | -1.49% | 10↑ 28↓of 38 | — | — |
| Organon LLC | 62 | 1G/61B | $76.3590 | -0.04% | 10↑ 23↓of 33 | — | 14 |
| PAI Holdings LLC | 60 | 60G/0B | $4.2500 | +1.37% | 23↑ 23↓of 46 | 3 | 3 |
| PuraCap Laboratories LLC | 59 | 59G/0B | $0.6490 | +1.85% | 33↑ 17↓of 50 | 1 | — |
| Carlsbad Technology Inc. | 56 | 56G/0B | $0.1072 | -0.27% | 24↑ 26↓of 50 | — | — |
| Camber Consumer Care | 56 | 56G/0B | $0.1597 | -0.73% | 15↑ 39↓of 54 | — | — |
| Cranbury Pharmaceuticals, LLC | 56 | 56G/0B | $0.1682 | -0.03% | 26↑ 26↓of 52 | 1 | 1 |
| Novo Nordisk | 55 | 8G/47B | $181.65 | +0.01% | 16↑ 16↓of 32 | — | 1 |
| Pharmacia & Upjohn Company LLC | 55 | 0G/55B | $25.2697 | -0.06% | 6↑ 10↓of 16 | 1 | 9 |
| Sanofi-Aventis U.S. LLC | 54 | 17G/37B | $200.15 | -1.02% | 12↑ 18↓of 30 | — | 7 |
| Eywa Pharma Inc | 51 | 51G/0B | $0.4285 | -0.34% | 17↑ 18↓of 35 | — | — |
| McKesson | 50 | 50G/0B | $0.2586 | +0.59% | 9↑ 9↓of 18 | 3 | — |
| Laurus Labs Limited | 50 | 50G/0B | $0.3515 | +0.58% | 31↑ 14↓of 45 | — | — |
| Precision Dose Inc. | 48 | 48G/0B | $0.3830 | -0.56% | 16↑ 28↓of 44 | 1 | 1 |
| Alcon Laboratories, Inc. | 48 | 4G/44B | $12.1066 | -0.21% | 19↑ 16↓of 35 | — | 3 |
| Acella Pharmaceuticals, LLC | 48 | 48G/0B | $1.0277 | -0.38% | 24↑ 15↓of 39 | — | 2 |
| Florida Pharmaceutical Products, LLC | 48 | 48G/0B | $1.1295 | -2.04% | 10↑ 22↓of 32 | — | 1 |
| Bayer HealthCare LLC | 47 | 0G/47B | $0.5913 | — | — | — | 3 |
| Edenbridge Pharmaceuticals LLC | 46 | 46G/0B | $0.8357 | +0.08% | 21↑ 21↓of 42 | — | 1 |
| Elite Laboratories, Inc. | 46 | 46G/0B | $0.7777 | -0.25% | 20↑ 26↓of 46 | — | — |
| Trigen Laboratories, LLC | 45 | 45G/0B | $3.7068 | -0.81% | 23↑ 19↓of 42 | 1 | 2 |
| Quagen Pharmaceuticals LLC | 44 | 44G/0B | $0.3292 | -0.48% | 19↑ 22↓of 41 | — | — |
| Wilshire Pharmaceuticals Inc. | 42 | 42G/0B | $2.4460 | +2.05% | 16↑ 23↓of 39 | — | 1 |
| Par Health USA, LLC | 42 | 39G/3B | $3.7246 | -1.84% | 11↑ 20↓of 31 | — | 1 |
| Ohm Laboratories Inc. | 40 | 40G/0B | $0.2506 | -1.75% | 4↑ 29↓of 33 | — | 1 |
| Winder Laboratories LLC | 40 | 40G/0B | $0.9704 | +1.24% | 21↑ 16↓of 37 | — | — |
| Apnar Pharma LP | 37 | 37G/0B | $0.1393 | -0.42% | 14↑ 18↓of 32 | — | — |
| Mullan Pharmaceutical Inc. | 37 | 37G/0B | $1.7982 | +1.26% | 24↑ 12↓of 36 | — | — |
| UCB, Inc. | 37 | 0G/37B | $1006.52 | -0.01% | 11↑ 14↓of 25 | — | 3 |
| Sunrise Pharmaceutical Inc. | 37 | 37G/0B | $0.1806 | +0.84% | 17↑ 17↓of 34 | — | 1 |
| ACI Healthcare USA, Inc. | 36 | 36G/0B | $0.0611 | +1.97% | 16↑ 1↓of 17 | — | — |
| Baxter Healthcare Corporation | 35 | 35G/0B | $8.3325 | -0.44% | 6↑ 7↓of 13 | 1 | 1 |
| Vitruvias Therapeutics Inc. | 34 | 34G/0B | $2.1545 | -2.34% | 10↑ 21↓of 31 | — | — |
| Azurity Pharmaceuticals Inc. | 34 | 1G/33B | $5.7887 | -0.01% | 9↑ 5↓of 14 | 1 | 8 |
| Burel Pharmaceuticals, LLC | 33 | 33G/0B | $0.5737 | +0.03% | 14↑ 14↓of 28 | 1 | — |
| Amici Pharmaceuticals LLC | 32 | 32G/0B | $0.6750 | +1.07% | 14↑ 16↓of 30 | — | — |
| Amgen Inc. | 32 | 0G/32B | $875.18 | -0.02% | 3↑ 6↓of 9 | — | 1 |
| IBSA Pharma Inc. | 31 | 0G/31B | $5.3518 | — | — | — | 1 |
| Ritedose Pharmaceuticals, LLC | 30 | 30G/0B | $0.3300 | -1.02% | 12↑ 18↓of 30 | — | — |
| Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | 30 | 0G/30B | $10.5365 | -0.01% | 6↑ 13↓of 19 | — | 3 |
| TAGI Pharma Inc. | 29 | 29G/0B | $0.2435 | — | — | 1 | 1 |
| Civica, Inc. | 28 | 28G/0B | $3.6348 | +1.28% | 13↑ 7↓of 20 | — | — |
| Bayer HealthCare Pharmaceuticals Inc. | 28 | 0G/28B | $45.3779 | -0.06% | 9↑ 14↓of 23 | — | 1 |
| Otsuka America Pharmaceutical Inc. | 27 | 0G/27B | $721.33 | -0.01% | 8↑ 13↓of 21 | — | 2 |
| Novitium Pharma LLC | 27 | 27G/0B | $0.4966 | +0.05% | 10↑ 16↓of 26 | — | 1 |
| SOLA Pharmaceuticals LLC | 26 | 26G/0B | $1.0130 | -0.58% | 11↑ 14↓of 25 | — | — |
| Atlantis Consumer Healthcare, Inc. | 26 | 3G/23B | $0.2198 | -0.64% | 5↑ 12↓of 17 | — | 1 |
| Sigmapharm Laboratories LLC | 26 | 26G/0B | $3.1066 | -2.54% | 8↑ 16↓of 24 | 1 | — |
| Purdue Pharma LP | 25 | 0G/25B | $35.6050 | -0.03% | 6↑ 12↓of 18 | — | 1 |
| Galderma Laboratories, L.P. | 25 | 0G/25B | $11.4653 | -0.01% | 1↑ 3↓of 4 | — | 7 |
| Nephron Pharmaceuticals Corporation | 24 | 23G/1B | $0.2556 | -1.08% | 8↑ 11↓of 19 | 1 | — |
| Fosun Pharma USA Inc. | 24 | 24G/0B | $8.3562 | -2.22% | 7↑ 13↓of 20 | — | — |
| Ipca Laboratories Limited | 24 | 24G/0B | $0.0759 | -0.41% | 11↑ 13↓of 24 | — | — |
| Pacific Pharma, Inc. | 24 | 24G/0B | $5.5040 | -1.23% | 7↑ 13↓of 20 | — | 1 |
| E.R. Squibb & Sons, L.L.C. | 24 | 0G/24B | $177.86 | -0.01% | 8↑ 6↓of 14 | — | 3 |
| Noven Therapeutics, LLC | 23 | 5G/18B | $17.2912 | +0.58% | 7↑ 9↓of 16 | — | — |
| H2-Pharma LLC | 22 | 10G/12B | $25.2305 | -1.28% | 7↑ 9↓of 16 | 1 | 2 |
| Caplin Steriles Limited | 22 | 22G/0B | $2.7957 | -0.37% | 8↑ 11↓of 19 | — | 1 |
| Genus Lifesciences Inc. | 22 | 19G/3B | $1.5216 | -0.85% | 3↑ 13↓of 16 | — | 3 |
| Aarna USA Inc. | 21 | 21G/0B | $0.1268 | -0.74% | 4↑ 17↓of 21 | — | — |
| Almatica Pharma LLC | 21 | 7G/14B | $10.5844 | -2.00% | 3↑ 9↓of 12 | — | 8 |
| Devatis Inc. | 20 | 20G/0B | $5.3011 | -2.39% | 3↑ 8↓of 11 | — | — |
| American Regent, Inc. | 20 | 17G/3B | $8.6087 | +0.66% | 5↑ 7↓of 12 | — | 2 |
| WG Critical Care, LLC | 19 | 19G/0B | $6.7653 | +0.67% | 6↑ 1↓of 7 | — | 1 |
| Amphastar Pharmaceuticals, Inc. | 19 | 17G/2B | $78.9863 | -3.21% | 1↑ 11↓of 12 | — | — |
| Yiling Pharmaceutical Inc. | 19 | 19G/0B | $0.1560 | — | — | — | — |
| The Procter & Gamble Manufacturing Company | 18 | 0G/18B | $0.2947 | — | — | — | — |
| Astellas Pharma US, Inc. | 18 | 0G/18B | $17.5112 | +0.06% | 4↑ 2↓of 6 | — | 2 |
| Gilead Sciences, Inc. | 18 | 0G/18B | $286.54 | +0.06% | 5↑ 2↓of 7 | — | 2 |
| Oryza Pharmaceuticals Inc. | 18 | 18G/0B | $0.1322 | -4.89% | 2↑ 16↓of 18 | — | — |
| Neolpharma, Inc. | 17 | 17G/0B | $0.0557 | -0.47% | 5↑ 12↓of 17 | — | — |
| Reliable 1 Laboratories LLC | 17 | 17G/0B | $0.0268 | — | — | — | — |
| Vertical Pharmaceuticals, LLC | 17 | 3G/14B | $8.2522 | -0.48% | 4↑ 6↓of 10 | — | 2 |
| Amici Pharma, Inc | 16 | 16G/0B | $0.4685 | -1.05% | 8↑ 8↓of 16 | — | — |
| Tris Pharma Inc | 16 | 16G/0B | $0.3577 | +1.61% | 4↑ 2↓of 6 | — | 1 |
| Teva Neuroscience, Inc. | 16 | 0G/16B | $244.39 | -0.18% | 3↑ 9↓of 12 | — | 1 |
| Vensun Pharmaceuticals, Inc. | 15 | 15G/0B | $0.0549 | — | — | — | — |
| Seton Pharmaceuticals | 15 | 15G/0B | $21.3656 | — | — | — | — |
| Sumitomo Pharma America, Inc. | 15 | 0G/15B | $42.4128 | +0.03% | 6↑ 3↓of 9 | — | 2 |
| e5 Pharma, LLC | 15 | 15G/0B | $0.6040 | +3.49% | 11↑ 4↓of 15 | — | — |
| Eisai Inc. | 15 | 0G/15B | $22.0941 | +0.01% | 5↑ 4↓of 9 | — | 2 |
| Xellia Pharmaceuticals USA LLC | 15 | 15G/0B | $12.1891 | +2.04% | 3↑ 1↓of 4 | — | — |
| Genentech, Inc. | 15 | 0G/15B | $196.52 | +0.09% | 3↑ 3↓of 6 | — | 2 |
| Bausch & Lomb Americas Inc. | 15 | 15G/0B | $13.0115 | +0.45% | 5↑ 10↓of 15 | — | 1 |
| B. Braun Medical Inc. | 15 | 15G/0B | $0.0047 | +1.05% | 3↑ 0↓of 3 | — | — |
| Natco Pharma USA LLC | 15 | 15G/0B | $0.3084 | -0.41% | 5↑ 8↓of 13 | — | — |
| Neos Therapeutics Brands, LLC | 15 | 6G/9B | $16.6623 | -0.54% | 0↑ 15↓of 15 | — | 1 |
| Armas Pharmaceuticals Inc. | 15 | 15G/0B | $1.5677 | -0.31% | 4↑ 3↓of 7 | 1 | 1 |
| Trifluent Pharma LLC | 15 | 15G/0B | $5.9604 | -1.90% | 6↑ 7↓of 13 | — | 2 |
| Salix Pharmaceuticals Inc. | 15 | 0G/15B | $105.14 | — | — | — | 1 |
| Supernus Pharmaceuticals Inc. | 15 | 0G/15B | $20.4819 | +0.05% | 2↑ 4↓of 6 | — | 2 |
| Solaris Pharma Corporation | 14 | 14G/0B | $1.9961 | +1.36% | 7↑ 7↓of 14 | — | — |
| Xttrium Laboratories, Inc. | 14 | 10G/4B | $0.0434 | +1.07% | 8↑ 4↓of 12 | — | — |
| YARAL Pharma Inc. | 14 | 14G/0B | $2.6555 | — | — | — | — |
| Archis Pharma LLC | 14 | 14G/0B | $0.7259 | +0.90% | 5↑ 4↓of 9 | — | 1 |
| Saptalis Pharmaceuticals LLC | 13 | 11G/2B | $0.9351 | -0.05% | 6↑ 7↓of 13 | — | 1 |
| Provell Pharmaceuticals, LLC | 13 | 0G/13B | $0.1719 | — | — | — | — |
| Janssen Products LP | 13 | 0G/13B | $190.43 | -0.01% | 2↑ 6↓of 8 | — | 2 |
| Llorens Pharmaceutical International Division | 13 | 13G/0B | $0.0976 | -1.14% | 1↑ 6↓of 7 | — | — |
| BE Pharmaceuticals Inc. | 13 | 13G/0B | $10.5250 | -2.17% | 2↑ 7↓of 9 | — | — |
| ViiV Healthcare Company | 13 | 0G/13B | $60.6366 | +0.06% | 3↑ 2↓of 5 | — | 3 |
| NextWave Pharmaceuticals, Inc | 13 | 0G/13B | $8.9300 | -0.05% | 4↑ 7↓of 11 | — | 1 |
| Pharbest Pharmaceuticals, Inc. | 13 | 13G/0B | $0.0255 | — | — | — | — |
| Innogenix, Inc. | 13 | 13G/0B | $0.1626 | — | — | — | — |
| USAntibiotics, LLC | 13 | 13G/0B | $0.1796 | +2.20% | 7↑ 5↓of 12 | — | — |
| Collegium Pharmaceutical, Inc. | 13 | 0G/13B | $17.5109 | — | — | — | — |
| Afaxys Pharma, LLC | 13 | 13G/0B | $0.6085 | -0.98% | 4↑ 9↓of 13 | — | — |
| Patrin Pharma Inc. | 12 | 12G/0B | $0.4647 | +1.63% | 7↑ 3↓of 10 | 1 | 1 |
| Mission Pharmacal Company | 12 | 2G/10B | $4.3272 | -0.27% | 1↑ 1↓of 2 | — | 3 |
| Nordic Pharma, Inc. | 12 | 12G/0B | $5.6475 | -0.22% | 6↑ 6↓of 12 | — | — |
| i3 Pharmaceuticals, LLC | 12 | 12G/0B | $1.8565 | +1.29% | 8↑ 3↓of 11 | — | — |
| Roerig | 12 | 0G/12B | $23.0818 | — | — | — | 3 |
| Poly Pharmaceuticals, Inc. | 11 | 11G/0B | $0.5264 | -0.16% | 0↑ 1↓of 1 | — | — |
| C.B. Fleet Company, Inc. | 11 | 0G/11B | $0.1011 | -0.07% | 1↑ 1↓of 2 | — | 2 |
| Zameer Pharmaceuticals LLC | 11 | 11G/0B | $0.6869 | -0.79% | 0↑ 2↓of 2 | — | 3 |
| Crown Laboratories | 11 | 9G/2B | $0.2542 | — | — | — | 1 |
| CarWin Pharmaceutical Associates LLC | 11 | 2G/9B | $14.8143 | -10.83% | 0↑ 2↓of 2 | — | 3 |
| Larken Laboratories, Inc. | 11 | 11G/0B | $0.2076 | -2.15% | 1↑ 6↓of 7 | — | — |
| Edwards Pharmaceuticals, Inc. | 11 | 10G/1B | $0.8330 | -0.16% | 3↑ 4↓of 7 | — | — |
| Arbor Pharmaceuticals, Inc. | 11 | 11G/0B | $3.6368 | -1.96% | 2↑ 2↓of 4 | — | — |
| Novugen Pharma (USA) LLC | 11 | 11G/0B | $0.6321 | -0.67% | 5↑ 6↓of 11 | — | — |
| TWi Pharmaceuticals, Inc. | 11 | 11G/0B | $0.1379 | -0.67% | 2↑ 3↓of 5 | — | — |
| Aimmune Therapeutics, Inc. | 10 | 0G/10B | $8.5787 | +0.04% | 7↑ 1↓of 8 | — | — |
| Cambridge Therapeutics Technologies, LLC | 10 | 10G/0B | $0.2930 | — | — | — | 1 |
| Teva Parenteral Medicines, Inc. | 10 | 10G/0B | $2.8362 | +1.88% | 3↑ 1↓of 4 | — | 1 |
| Exeltis USA, Inc. | 10 | 0G/10B | $7.7871 | -0.07% | 2↑ 4↓of 6 | — | 1 |
| VistaPharm, LLC | 10 | 10G/0B | $0.7809 | +1.86% | 7↑ 1↓of 8 | — | 1 |
| Alkermes, Inc. | 10 | 0G/10B | $697.54 | — | 5↑ 4↓of 9 | — | — |
| Currax Pharmaceuticals LLC | 10 | 3G/7B | $24.6196 | — | — | — | 1 |
| Janssen Biotech, Inc. | 10 | 0G/10B | $13099.89 | -0.04% | 1↑ 2↓of 3 | — | 1 |
| CivicaScript LLC | 10 | 10G/0B | $0.6878 | -2.05% | 3↑ 6↓of 9 | — | — |
| SK Life Science, Inc. | 10 | 0G/10B | $35.2954 | -0.04% | 2↑ 6↓of 8 | — | — |
| Hepalink USA Inc. | 10 | 10G/0B | $6.7713 | -2.90% | 1↑ 8↓of 9 | — | — |
| Sheffield Pharmaceuticals LLC | 10 | 10G/0B | $0.1001 | -0.21% | 2↑ 5↓of 7 | — | — |
| EMD Serono, Inc. | 9 | 0G/9B | $1430.02 | -0.02% | 0↑ 1↓of 1 | — | — |
| Apozeal Pharmaceuticals Inc. | 9 | 9G/0B | $0.0422 | -2.01% | 2↑ 7↓of 9 | — | — |
| Axsome Therapeutics, Inc. | 9 | 0G/9B | $38.1432 | — | 3↑ 2↓of 5 | — | — |
| Carnegie Pharmaceuticals LLC | 9 | 7G/2B | $1.2951 | -0.09% | 2↑ 5↓of 7 | — | — |
| International Medication Systems, Limited | 9 | 9G/0B | $4.8341 | -2.69% | 1↑ 5↓of 6 | — | 1 |
| Virtus Pharmaceuticals, LLC | 9 | 9G/0B | $2.1777 | -0.61% | 0↑ 2↓of 2 | — | 2 |
| Person and Covey | 9 | 4G/5B | $0.0985 | -2.51% | 2↑ 2↓of 4 | — | — |
| XGen Pharmaceuticals DJB, Inc. | 9 | 9G/0B | $10.2974 | -1.76% | 2↑ 3↓of 5 | — | — |
| Nomax Inc. | 9 | 9G/0B | $0.4154 | +0.11% | 9↑ 0↓of 9 | — | — |
| Antares Pharma, Inc. | 9 | 0G/9B | $325.27 | -0.02% | 1↑ 3↓of 4 | — | 1 |
| Avet Pharmaceuticals Inc. | 9 | 9G/0B | $0.9956 | -0.65% | 4↑ 5↓of 9 | — | — |
| CMP Pharma, Inc. | 9 | 5G/4B | $2.5333 | +1.61% | 5↑ 1↓of 6 | 1 | 1 |
| Avion Pharmaceuticals, LLC | 9 | 0G/9B | $8.4335 | +0.11% | 2↑ 0↓of 2 | — | 1 |
| ARMAS PHARMACEUTICALS INC. | 9 | 9G/0B | $9.0827 | +0.37% | 3↑ 6↓of 9 | — | 1 |
| Gabar Health Sciences Corp. | 8 | 8G/0B | $0.2666 | — | — | 1 | — |
| Medimetriks Pharmaceuticals Inc. | 8 | 4G/4B | $40.7720 | +0.73% | 2↑ 2↓of 4 | — | 4 |
| Cephalon, LLC | 8 | 0G/8B | $47.2461 | +0.03% | 1↑ 0↓of 1 | — | 2 |
| Neurelis, Inc | 8 | 0G/8B | $366.16 | -0.03% | 0↑ 4↓of 4 | — | — |
| Avenacy Inc. | 8 | 8G/0B | $30.2825 | -1.43% | 2↑ 3↓of 5 | — | — |
| BioDelivery Sciences International Inc | 8 | 0G/8B | $14.1507 | — | 5↑ 3↓of 8 | — | — |
| Omnivium Pharmaceuticals LLC | 8 | 8G/0B | $1.7563 | -2.85% | 1↑ 4↓of 5 | — | 2 |
| Harrow Eye, LLC | 8 | 0G/8B | $91.4261 | -0.01% | 2↑ 3↓of 5 | — | 2 |
| Validus Pharmaceuticals LLC | 8 | 0G/8B | $2.5644 | +0.11% | 2↑ 2↓of 4 | — | 3 |
| Ferring Pharmaceuticals Inc. | 8 | 1G/7B | $168.09 | -0.14% | 0↑ 2↓of 2 | — | 1 |
| Teva Respiratory, LLC | 8 | 0G/8B | $131.25 | +0.06% | 2↑ 1↓of 3 | — | 2 |
| Medexus Pharma Inc. | 7 | 0G/7B | $542.65 | +0.28% | 2↑ 1↓of 3 | — | 1 |
| Fougera Pharmaceuticals Inc. | 7 | 7G/0B | $2.0200 | +0.68% | 4↑ 1↓of 5 | — | — |
| Catalyst Pharmaceuticals, Inc. | 7 | 0G/7B | $31.3995 | +0.03% | 5↑ 2↓of 7 | — | — |
| Indivior Inc. | 7 | 0G/7B | $704.56 | -0.04% | 1↑ 4↓of 5 | — | 1 |
| OWP Pharmaceuticals, Inc. | 7 | 7G/0B | $4.1558 | -1.00% | 0↑ 5↓of 5 | — | 1 |
| Daiichi Sankyo Inc. | 7 | 0G/7B | $14.6260 | — | — | — | 1 |
| Advanz Pharma (US) Corp. | 7 | 0G/7B | $12.8504 | — | — | — | 3 |
| U.S. Pharmaceutical Corporation | 7 | 0G/7B | $0.7815 | +10.01% | 5↑ 0↓of 5 | — | — |
| Sebela Pharmaceuticals Inc. | 7 | 0G/7B | $21.1074 | — | — | — | 1 |
| Santarus Inc. | 7 | 0G/7B | $81.9991 | — | — | — | 3 |
| Vanda Pharmaceuticals Inc. | 7 | 0G/7B | $41.0228 | -0.02% | 3↑ 3↓of 6 | — | — |
| Digestive Care, Inc. | 6 | 0G/6B | $5.3440 | +0.06% | 4↑ 2↓of 6 | — | — |
| Melinta Therapeutics, LLC | 6 | 0G/6B | $25.4657 | — | — | — | 1 |
| Mannkind Corporation | 6 | 0G/6B | $10.3975 | +0.47% | 1↑ 0↓of 1 | — | — |
| PureTek Corporation | 6 | 6G/0B | $0.8953 | -1.64% | 0↑ 1↓of 1 | — | — |
| Foundation Consumer Healthcare LLC | 6 | 4G/2B | $14.6070 | — | — | — | 1 |
| Thea Pharma Inc. | 6 | 0G/6B | $29.1167 | +0.02% | 3↑ 2↓of 5 | — | 3 |
| Xeris Pharmaceuticals, Inc. | 6 | 0G/6B | $1868.00 | -0.11% | 1↑ 4↓of 5 | — | — |
| Hisun Pharmaceuticals USA Inc. | 6 | 6G/0B | $1.5957 | -1.17% | 1↑ 3↓of 4 | 1 | — |
| BioComp Pharma Inc. | 6 | 6G/0B | $1.0407 | +1.04% | 2↑ 3↓of 5 | — | — |
| Orexo US, Inc. | 6 | 0G/6B | $11.4075 | -0.02% | 1↑ 5↓of 6 | — | — |
| Vivus LLC | 6 | 0G/6B | $5.2303 | — | — | — | — |
| Kesin Pharma Corporation | 6 | 5G/1B | $0.6370 | -0.16% | 1↑ 3↓of 4 | — | — |
| Allegis Pharmaceuticals, LLC | 6 | 6G/0B | $6.8386 | -0.33% | 2↑ 3↓of 5 | — | — |
| INA Pharmaceutics Inc | 5 | 4G/1B | $8.5968 | -10.83% | 0↑ 2↓of 2 | — | 1 |
| Coloplast Manufacturing US, LLC | 5 | 4G/1B | $0.0663 | — | — | — | — |
| Covis Pharma US, Inc | 5 | 0G/5B | $27.5989 | -0.02% | 2↑ 3↓of 5 | — | 1 |
| Brookfield Pharmaceuticals, LLC | 5 | 5G/0B | $0.4933 | — | — | — | — |
| Hikma Specialty USA Inc. | 5 | 0G/5B | $17.1067 | +0.26% | 4↑ 0↓of 4 | — | 1 |
| Biocon Biologics Inc. | 5 | 2G/3B | $686.67 | +0.05% | 1↑ 3↓of 4 | — | — |
| Ironshore Pharmaceuticals Inc. | 5 | 0G/5B | $15.3995 | -0.01% | 1↑ 3↓of 4 | — | 1 |
| LEO Pharma Inc. | 5 | 0G/5B | $17.6629 | -0.03% | 1↑ 1↓of 2 | — | 2 |
| Leadiant Biosciences, Inc. | 5 | 0G/5B | $0.6160 | — | — | — | — |
| Oliva Therapeutics, LLC | 5 | 4G/1B | $0.3885 | -3.92% | 2↑ 2↓of 4 | — | — |
| Patriot Pharmaceuticals | 5 | 5G/0B | $13.9136 | -3.51% | 1↑ 1↓of 2 | — | 1 |
| Pharmaceutical Associates, Inc. | 5 | 5G/0B | $0.1899 | -2.88% | 0↑ 2↓of 2 | — | — |
| Provepharm Inc. | 5 | 5G/0B | $24.9900 | +4.32% | 2↑ 0↓of 2 | — | — |
| Rising Health, LLC | 5 | 5G/0B | $0.0834 | -4.11% | 2↑ 3↓of 5 | — | — |
| The J. Molner Company LLC | 5 | 5G/0B | $0.6223 | +2.96% | 3↑ 1↓of 4 | — | — |
| VGYAAN Pharmaceuticals LLC | 5 | 5G/0B | $52.5722 | — | — | — | 2 |
| Immunex Corporation | 4 | 0G/4B | $2082.30 | -0.06% | 0↑ 2↓of 2 | — | — |
| Hillestad Pharmaceuticals USA | 4 | 4G/0B | $0.2427 | -0.78% | 0↑ 3↓of 3 | — | — |
| Oncor Pharmaceuticals | 4 | 4G/0B | $0.1323 | -0.24% | 1↑ 3↓of 4 | — | — |
| Acertis Pharmaceuticals, LLC | 4 | 2G/2B | $15.0830 | +0.37% | 1↑ 2↓of 3 | — | 2 |
| Braintree Laboratories, Inc. | 4 | 0G/4B | $17.1791 | -0.01% | 0↑ 1↓of 1 | — | — |
| Aprecia Pharmaceuticals, LLC | 4 | 0G/4B | $10.2726 | — | — | — | 1 |
| Medicure International Inc | 4 | 0G/4B | $7.4073 | -0.04% | 0↑ 2↓of 2 | — | — |
| GenBioPro, Inc. | 4 | 4G/0B | $0.7142 | -2.02% | 0↑ 3↓of 3 | — | — |
| Quinn Pharmaceuticals | 4 | 4G/0B | $0.1598 | -0.89% | 3↑ 1↓of 4 | — | — |
| GM Pharmaceuticals, INC | 4 | 1G/3B | $0.1844 | +1.69% | 1↑ 0↓of 1 | — | — |
| Fresenius Kabi, LLC | 4 | 4G/0B | $4.4165 | — | — | — | — |
| Phathom Pharmaceuticals Inc. | 4 | 0G/4B | $14.9558 | -0.03% | 0↑ 3↓of 3 | — | — |
| TOLMAR Inc. | 4 | 1G/3B | $8.9829 | -0.24% | 1↑ 3↓of 4 | — | — |
| Vista Pharmaceuticals, Inc. | 4 | 4G/0B | $0.0788 | — | — | — | 1 |
| Duchesnay USA, Inc. | 4 | 0G/4B | $7.2842 | +0.04% | 2↑ 2↓of 4 | — | 1 |
| Cameron Pharmaceuticals | 4 | 4G/0B | $1.3466 | +1.12% | 3↑ 1↓of 4 | — | — |
| Dista Products Company | 4 | 0G/4B | $16.4383 | — | — | — | 1 |
| Beach Products, Inc. | 4 | 4G/0B | $0.4767 | +13.27% | 4↑ 0↓of 4 | — | — |
| ACI Healthcare USA Inc. | 4 | 4G/0B | $0.0367 | +0.37% | 1↑ 1↓of 2 | — | — |
| SDA Laboratories, Inc. | 4 | 4G/0B | $0.0285 | — | — | — | — |
| Marnel Pharmaceuticals, Inc. | 3 | 3G/0B | $2.2079 | — | — | — | — |
| BF ASCHER AND CO INC | 3 | 1G/2B | $0.0589 | — | — | — | — |
| Lundbeck Pharmaceuticals LLC | 3 | 0G/3B | $34.0673 | -0.11% | 0↑ 2↓of 2 | — | 1 |
| Long Grove Pharmaceuticals, LLC | 3 | 3G/0B | $5.3319 | -0.36% | 1↑ 2↓of 3 | — | — |
| Vifor Pharma, Inc. | 3 | 0G/3B | $37.8209 | — | 2↑ 1↓of 3 | — | — |
| Lifsa Drugs LLC | 3 | 3G/0B | $9.8841 | — | — | — | 1 |
| Lexicon Pharmaceuticals, Inc. | 3 | 0G/3B | $20.1582 | -0.44% | 0↑ 2↓of 2 | — | — |
| Laser Pharmaceuticals, LLC | 3 | 3G/0B | $1.0092 | — | — | — | 1 |
| Intra-Cellular Therapies, Inc | 3 | 0G/3B | $57.2302 | -0.02% | 1↑ 2↓of 3 | — | — |
| WOMENS CHOICE PHARMACEUTICALS LLC | 3 | 1G/2B | $3.1567 | — | — | — | — |
| West-Ward Pharmaceuticals Corp | 3 | 3G/0B | $0.2997 | — | — | — | 1 |
| Greenstone LLC | 3 | 3G/0B | $0.9269 | +0.13% | 2↑ 0↓of 2 | — | — |
| Genzyme Corporation | 3 | 0G/3B | $13.3447 | — | — | — | 1 |
| GRIFOLS USA, LLC | 3 | 0G/3B | $3.5465 | — | — | — | — |
| ALK-Abello A S | 3 | 0G/3B | $11.7296 | -0.04% | 0↑ 2↓of 2 | — | — |
| CIMA LABS INC. | 3 | 3G/0B | $0.3157 | +0.57% | 1↑ 1↓of 2 | — | — |
| Cumberland Pharmaceuticals Inc. | 3 | 0G/3B | $235.14 | +0.16% | 2↑ 1↓of 3 | — | — |
| Savage Laboratories a division of Fougera Pharmaceuticals Inc. | 3 | 0G/3B | $1.6276 | +0.01% | 1↑ 1↓of 2 | — | — |
| CDMA | 3 | 3G/0B | $0.0136 | -1.13% | 0↑ 3↓of 3 | — | — |
| Royal Pharmaceuticals | 3 | 0G/3B | $0.5378 | +0.21% | 3↑ 0↓of 3 | — | — |
| RedHill Biopharma Ltd | 3 | 0G/3B | $11.3570 | -0.05% | 0↑ 1↓of 1 | — | — |
| Aquestive Therapeutics | 3 | 0G/3B | $38.1963 | — | — | — | 1 |
| Affordable Pharmaceuticals, LLC | 3 | 3G/0B | $0.0331 | -3.63% | 1↑ 2↓of 3 | — | — |
| Quest Products, LLC | 3 | 0G/3B | $0.3809 | -0.21% | 1↑ 2↓of 3 | — | 1 |
| Teva Women's Health, Inc. | 3 | 0G/3B | $36.1443 | — | — | — | 1 |
| Capital Pharma | 3 | 0G/3B | $0.2381 | — | — | — | — |
| Puro Pharma Inc. | 3 | 3G/0B | $0.6908 | -5.85% | 0↑ 3↓of 3 | — | 1 |
| Piramal Critical Care | 3 | 3G/0B | $1.4275 | +2.28% | 1↑ 0↓of 1 | — | — |
| kaleo, Inc | 3 | 0G/3B | $309.59 | — | — | — | — |
| Phlow Corporation | 3 | 3G/0B | $0.5193 | +3.21% | 2↑ 0↓of 2 | — | — |
| Arcutis Biotherapeutics, Inc. | 3 | 0G/3B | $15.3868 | +0.02% | 2↑ 0↓of 2 | — | 1 |
| OPKO Pharmaceuticals LLC | 3 | 0G/3B | $40.4433 | -0.06% | 0↑ 1↓of 1 | — | — |
| Aucta Pharmaceuticals, Inc. | 3 | 0G/3B | $21.4810 | — | — | — | 1 |
| Neurocrine Biosciences, Inc. | 3 | 0G/3B | $275.20 | — | — | — | — |
| Millicent US, Inc. | 3 | 0G/3B | $600.89 | -0.14% | 0↑ 3↓of 3 | — | — |
| Adare Pharmaceuticals Inc | 3 | 3G/0B | $0.1265 | — | — | — | — |
| Corium, LLC. | 3 | 0G/3B | $14.4107 | -0.02% | 0↑ 3↓of 3 | — | — |
| Valinor Pharma, LLC | 3 | 0G/3B | $14.6084 | +0.08% | 2↑ 1↓of 3 | — | — |